Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis
Background: Conflicting data have been reported on the prognostic impact of the extent of lymphadenectomy during esophagectomy for esophageal cancer (EC) after neoadjuvant therapy, especially after neoadjuvant chemoradiotherapy (nCRT). Methods: A comprehensive online search was performed to explore...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537020301759 |
_version_ | 1819112912097116160 |
---|---|
author | Donglai Chen Yiming Mao Yuhang Xue Yonghua Sang Desen Liu Yongbing Chen |
author_facet | Donglai Chen Yiming Mao Yuhang Xue Yonghua Sang Desen Liu Yongbing Chen |
author_sort | Donglai Chen |
collection | DOAJ |
description | Background: Conflicting data have been reported on the prognostic impact of the extent of lymphadenectomy during esophagectomy for esophageal cancer (EC) after neoadjuvant therapy, especially after neoadjuvant chemoradiotherapy (nCRT). Methods: A comprehensive online search was performed to explore the association between increased lymph node yield (LNY) and survival of patients with EC, in which the overall survival (OS) was set as the primary outcome. In addition to analysis of the entire cohort, subgroup analyses of different induction therapy and different populations were also performed. Findings: A total of 19528 patients from twelve studies were included in our study. The pooled data revealed that more lymph node harvested was associated with better OS (HR = 0·87; 95% CI: 0·79–0·95, p < 0·001). Notably, a higher LNY was associated with better OS if the threshold was less than 18. However, more thorough lymphadenectomy might not bring additional survival benefits when it came to a cutoff value more than 18. The subgroup analysis further revealed that a higher LNY after nCRT was associated favorable survival. In terms of subset analysis of different populations, increased LNY was associated with longer OS in Western populations but not in Eastern. Interpretation: Increased LNY during esophagectomy after neoadjuvant therapy, especially after nCRT, might be associated with improved OS. More studies are warranted to assess the survival benefits of a higher LNY receiving neoadjuvant therapy plus esophagectomy, especially in Eastern populations. Funding: Supported by the projects from Suzhou Key Laboratory of Thoracic Oncology (SZS201907), Suzhou Key Discipline for Medicine (SZXK201803), the Science and Technology Research Foundation of Suzhou Municipality (SYS2018063, SYS2018064), Municipal Program of People's Livelihood Science and Technology in Suzhou (SS2019061) and Major Project for Social Development, Jiangsu Provincial Department of Science and Technology (SBE2020750085). |
first_indexed | 2024-12-22T04:21:02Z |
format | Article |
id | doaj.art-047e4630fe044f15a61c3644362d75f7 |
institution | Directory Open Access Journal |
issn | 2589-5370 |
language | English |
last_indexed | 2024-12-22T04:21:02Z |
publishDate | 2020-08-01 |
publisher | Elsevier |
record_format | Article |
series | EClinicalMedicine |
spelling | doaj.art-047e4630fe044f15a61c3644362d75f72022-12-21T18:39:17ZengElsevierEClinicalMedicine2589-53702020-08-0125100431Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysisDonglai Chen0Yiming Mao1Yuhang Xue2Yonghua Sang3Desen Liu4Yongbing Chen5Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, ChinaDepartment of Thoracic Surgery, Suzhou Kowloon Hospital Shanghai Jiaotong University School of Medicine, Suzhou, ChinaDepartment of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, ChinaDepartment of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China; Corresponding authors.Department of Thoracic Surgery, Suzhou Kowloon Hospital Shanghai Jiaotong University School of Medicine, Suzhou, China; Corresponding authors.Department of Thoracic Surgery, The Second Affiliated Hospital of Soochow University, Suzhou, China; Corresponding author.Background: Conflicting data have been reported on the prognostic impact of the extent of lymphadenectomy during esophagectomy for esophageal cancer (EC) after neoadjuvant therapy, especially after neoadjuvant chemoradiotherapy (nCRT). Methods: A comprehensive online search was performed to explore the association between increased lymph node yield (LNY) and survival of patients with EC, in which the overall survival (OS) was set as the primary outcome. In addition to analysis of the entire cohort, subgroup analyses of different induction therapy and different populations were also performed. Findings: A total of 19528 patients from twelve studies were included in our study. The pooled data revealed that more lymph node harvested was associated with better OS (HR = 0·87; 95% CI: 0·79–0·95, p < 0·001). Notably, a higher LNY was associated with better OS if the threshold was less than 18. However, more thorough lymphadenectomy might not bring additional survival benefits when it came to a cutoff value more than 18. The subgroup analysis further revealed that a higher LNY after nCRT was associated favorable survival. In terms of subset analysis of different populations, increased LNY was associated with longer OS in Western populations but not in Eastern. Interpretation: Increased LNY during esophagectomy after neoadjuvant therapy, especially after nCRT, might be associated with improved OS. More studies are warranted to assess the survival benefits of a higher LNY receiving neoadjuvant therapy plus esophagectomy, especially in Eastern populations. Funding: Supported by the projects from Suzhou Key Laboratory of Thoracic Oncology (SZS201907), Suzhou Key Discipline for Medicine (SZXK201803), the Science and Technology Research Foundation of Suzhou Municipality (SYS2018063, SYS2018064), Municipal Program of People's Livelihood Science and Technology in Suzhou (SS2019061) and Major Project for Social Development, Jiangsu Provincial Department of Science and Technology (SBE2020750085).http://www.sciencedirect.com/science/article/pii/S2589537020301759Esophageal cancerLymph nodesNeoadjuvant therapySurgeryPrognosis |
spellingShingle | Donglai Chen Yiming Mao Yuhang Xue Yonghua Sang Desen Liu Yongbing Chen Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis EClinicalMedicine Esophageal cancer Lymph nodes Neoadjuvant therapy Surgery Prognosis |
title | Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis |
title_full | Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis |
title_fullStr | Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis |
title_full_unstemmed | Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis |
title_short | Does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy? A systematic review and updated meta-analysis |
title_sort | does the lymph node yield affect survival in patients with esophageal cancer receiving neoadjuvant therapy plus esophagectomy a systematic review and updated meta analysis |
topic | Esophageal cancer Lymph nodes Neoadjuvant therapy Surgery Prognosis |
url | http://www.sciencedirect.com/science/article/pii/S2589537020301759 |
work_keys_str_mv | AT donglaichen doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis AT yimingmao doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis AT yuhangxue doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis AT yonghuasang doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis AT desenliu doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis AT yongbingchen doesthelymphnodeyieldaffectsurvivalinpatientswithesophagealcancerreceivingneoadjuvanttherapyplusesophagectomyasystematicreviewandupdatedmetaanalysis |